AI assistant
Axogen, Inc. — Director's Dealing 2025
Dec 10, 2025
32414_dirs_2025-12-10_db36f8e1-a25c-4f08-9d28-203ccdce0e59.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Axogen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2025-12-08
Reporting Person: JOHNSON JOHN (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-12-08 | Common Stock | S | 11802 | $31.26 | Disposed | 13141 | Direct |
| 2025-12-08 | Common Stock | M | 11891 | $6.30 | Acquired | 25032 | Direct |
| 2025-12-08 | Common Stock | S | 11891 | $31.223 | Disposed | 13141 | Direct |
| 2025-12-09 | Common Stock | M | 8545 | $6.30 | Acquired | 21686 | Direct |
| 2025-12-09 | Common Stock | S | 8545 | $29.982 | Disposed | 13141 | Direct |
| 2025-12-09 | Common Stock | S | 13141 | $29.982 | Disposed | 0 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-12-08 | Stock Option (right to purchase) | $6.30 | M | 11891 | Disposed | 2033-09-01 | Common Stock (11891) | Direct |
| 2025-12-09 | Stock Option (right to purchase) | $6.30 | M | 8545 | Disposed | 2033-09-01 | Common Stock (8545) | Direct |
Footnotes
F1: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $31.00 to $31.57 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $29.98 to $30.02 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F3: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $29.90 to $30.09 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F4: Non-qualified stock option portion of the 2023 annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The grant became fully vested on September 1, 2024, the one-year anniversary of the grant date.